Terms: = Pancreatic cancer AND SSX1, MGC5162, 6756, ENSG00000126752, RP11-552E4_1, SSRC, MGC150425, Q16384 AND Treatment
13708 results:
1. Expression of somatostatin receptors in hemangioblastomas associated with von Hippel-Lindau disease as a novel diagnostic, therapeutic, and follow-up opportunity: A case report and literature review.
Brabo EP; de Almeida SA; Rafful PP; Rosado-de-Castro PH; Vieira Neto L
Arch Endocrinol Metab; 2024 May; 68():e230181. PubMed ID: 38788146
[TBL] [Abstract] [Full Text] [Related]
2. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
[TBL] [Abstract] [Full Text] [Related]
3. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
[TBL] [Abstract] [Full Text] [Related]
4. Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
Arias-Lorza AM; Costello JR; Hingorani SR; Von Hoff DD; Korn RL; Raghunand N
Sci Rep; 2024 May; 14(1):11570. PubMed ID: 38773189
[TBL] [Abstract] [Full Text] [Related]
5. Role of peritumoral tissue analysis in predicting characteristics of hepatocellular carcinoma using ultrasound-based radiomics.
Qian H; Huang Y; Xu L; Fu H; Lu B
Sci Rep; 2024 May; 14(1):11538. PubMed ID: 38773179
[TBL] [Abstract] [Full Text] [Related]
6. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.
Yamada R; Kuriyama N; Tanaka T; Nose K; Nakamura Y; Miwata T; Tsuboi J; Mizuno S; Nakagawa H
BMC Gastroenterol; 2024 May; 24(1):174. PubMed ID: 38769494
[TBL] [Abstract] [Full Text] [Related]
7. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
[TBL] [Abstract] [Full Text] [Related]
8. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for pancreatic Ductal Adenocarcinoma.
Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
[No Abstract] [Full Text] [Related]
9. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
[TBL] [Abstract] [Full Text] [Related]
10. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
Chen J; Li L; Feng Y; Zhao Y; Sun F; Zhou X; Yiqi D; Li Z; Kong F; Kong X
Cell Biol Toxicol; 2024 May; 40(1):30. PubMed ID: 38740637
[TBL] [Abstract] [Full Text] [Related]
11. Enrichment and Evaluation of Antitumor Properties of Total Flavonoids from
Yang S; Chu G; Wu J; Zhang G; Du L; Lin R
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731467
[TBL] [Abstract] [Full Text] [Related]
12. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
[TBL] [Abstract] [Full Text] [Related]
13. Exosomal PD-L1 in cancer and other fields: recent advances and perspectives.
Lu MM; Yang Y
Front Immunol; 2024; 15():1395332. PubMed ID: 38726017
[TBL] [Abstract] [Full Text] [Related]
14. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer.
Zhao J; Wang H; Chen J; Wang C; Gong N; Zhou F; Li X; Cao Y; Zhang H; Wang W; Zheng H; Zhang C
Biochem Biophys Res Commun; 2024 Jul; 718():149931. PubMed ID: 38723415
[TBL] [Abstract] [Full Text] [Related]
15. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract] [Full Text] [Related]
16. Immune checkpoint inhibitor associated diarrhoea.
Al-Hussainy A; Adams J; Simmons J; Kennedy J
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719255
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
Zhang L; Li M; Sun QF; Yu HP
Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
[TBL] [Abstract] [Full Text] [Related]
19. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
[TBL] [Abstract] [Full Text] [Related]
20. treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
Chang JY; Ruff SM; Cloyd JM
Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
[TBL] [Abstract] [Full Text] [Related]
[Next]